More of what matters, year after year10,11

3 Key Milestones.
A 10-Year
Follow-up Study.10

Deflazacort demonstrated differences
vs prednisone over time10

2018 Study

A prospective natural history observational cohort study with 440 patients ages 2 to 28 years, which evaluated the long-term effects of corticosteroids in DMD. Patients were followed up for 10 years. Patients were stratified by duration of corticosteroid treatment (<1 month or ≥12 months). Milestones for 9 groups of the Davis Duchenne Functional assessments were recorded and analyzed using Kaplan-Meier to measure disease progression.10

Deflazacort can help maintain muscle function, which may prolong ambulation10

Gaming like a 12-year-old

Acting with A mind toward lung function2

Not an actual patient.

Deflazacort Preserved Pulmonary Function Better Than Prednisone2

2020 Study

Results from a real-world, single-center, retrospective cohort analysis of 435 boys with DMD who attended the Comprehensive Neuromuscular Center at Cincinnati Children’s Hospital Medical Center (CCHMC) from 2004 to March 2017.2

Study Limitations

Comparisons between deflazacort and prednisone are not included in the Prescribing Information for deflazacort because prednisone is not an approved treatment for DMD.

Switching Corticosteroids
Safety Profile